Compare ARMP & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMP | III |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | 1500 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.7M | 197.1M |
| IPO Year | 1996 | 2006 |
| Metric | ARMP | III |
|---|---|---|
| Price | $3.66 | $6.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $17.50 | $6.80 |
| AVG Volume (30 Days) | 96.2K | ★ 222.1K |
| Earning Date | 11-11-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 2.92% |
| EPS Growth | N/A | ★ 216.67 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $192,745,000.00 |
| Revenue This Year | N/A | $4.24 |
| Revenue Next Year | N/A | $3.59 |
| P/E Ratio | ★ N/A | $51.50 |
| Revenue Growth | N/A | ★ 4.51 |
| 52 Week Low | $2.75 | $3.74 |
| 52 Week High | $14.98 | $6.45 |
| Indicator | ARMP | III |
|---|---|---|
| Relative Strength Index (RSI) | 49.63 | 73.47 |
| Support Level | $3.38 | $3.86 |
| Resistance Level | $4.07 | N/A |
| Average True Range (ATR) | 0.36 | 0.18 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 69.06 | 92.59 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.